JP MORGAN/CALL/PAYCHEX/130/0.1/17.01.25 Stock

Warrant

DE000JL1L192

Market Closed - Börse Stuttgart 02:58:22 2024-06-14 EDT
0.55 EUR +5.77% Intraday chart for JP MORGAN/CALL/PAYCHEX/130/0.1/17.01.25
Current month+34.15%
1 month-21.43%
Date Price Change
24-06-14 0.55 +5.77%
24-06-13 0.52 -16.13%
24-06-12 0.62 +19.23%
24-06-11 0.52 -3.70%
24-06-10 0.54 +3.85%

Delayed Quote Börse Stuttgart

Last update June 14, 2024 at 02:58 am

More quotes

Static data

Product typeWarrants
Buy / SellCALL
Underlying PAYCHEX, INC.
Issuer J.P. Morgan
WKN JL1L19
ISINDE000JL1L192
Date issued 2023-04-12
Strike 130 $
Maturity 2025-01-17 (216 Days)
Parity 10 : 1
Emission price 0.74
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 1.53
Lowest since issue 0.38
Delta0.42x
Omega 8.649
Premium11.44x
Gearing20.53x
Moneyness 0.9384
Difference Strike 8.01 $
Difference Strike %+6.16%
Spread 0.07
Spread %11.86%
Theoretical value 0.5550
Implied Volatility 22.51 %
Total Loss Probability 63.87 %
Intrinsic value 0.000000
Present value 0.5550
Break even 135.94 €
Theta-0.01x
Vega0.03x
Rho0.03x

Company Profile

Paychex, Inc. specializes in the development of integrated management software packages (ERP). The group also offers outsourcing services for small and mid-size companies. Net sales break down by activity sector as follows: - payroll and human resources management solutions (74.5%): management solutions for payroll, internal accounting data, taxes, employee benefits, pensions, etc.; - HR management solutions for professional employer organizations (23.5%): health insurance management, risk management and risk management, employee assistance schemes, etc.; - fund management (2%). All sales are in the United States.
Sector
-
More about the company

Ratings for Paychex, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings

Consensus: Paychex, Inc.

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
20
Last Close Price
122 USD
Average target price
120.9 USD
Spread / Average Target
-0.92%
Consensus